Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Ramirent in connection with its acquisition of JIAB
Mandate

Vinge advises Ramirent in connection with its acquisition of JIAB

March 21, 2023 Banking and Finance M&A Corporate Commercial IT, Telecommunications and Outsourcing Intellectual Property Real Estate and Construction

Vinge advises Ramirent AB in connection with its acquisition of JIAB Hyrcenter (consisting of the companies JIAB Hyrcenter AB and JIAB Boden AB). Ramirent thereby further strengthens its position in Norrbotten and as the largest machine rental company in Sweden.

Vinge’s team mainly consist of Jonas Johansson, Per Kling, Elsie Nassar and Nando Basic (M&A), Arvid Axelryd and Emma Gustavsson (IPR), Seyran Sahin and Ida Redander (Banking and finance), Anna Ståhlklo, Anna Högsten and Maja Eliasson (Employment), Martin Boström and Mario Saad (Corporate commercial), Karolina Fuhrman and Elis Allmark (IT & GDPR), Tove Tullberg and Julia Löfqvist (compliance), Rebecka Maltenius (real estate), and Emy Rydén and Ellinore Boström Andersson (project assistants).

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025